Moreover, chemotherapeutic agent-induced FOSB expression might contribute to a counterproductively poor prognosis in NSCLC by endowing tumor cells with increased proliferation and invasiveness [12, 13]. This evidence concerns the gene FOSB and non-small cell lung carcinoma.